We are live on ! Find out more
CCM

Carderock Capital Management Portfolio holdings

AUM $456M
1-Year Est. Return 31.89%
This Fund
S&P 500
This Quarter Est. Return
+12.05%
1 Year Est. Return
+31.89%
3 Year Est. Return
+88.65%
5 Year Est. Return
+111.4%
10 Year Est. Return
+513.53%
AUM
$362M
AUM Growth
+$64.2M
Cap. Flow
+$28.6M
Cap. Flow %
7.9%
Top 10 Hldgs %
31.1%
Holding
62
New
5
Increased
37
Reduced
16
Closed
1

Top Buys

Rank Stock Value
1
WST icon
West Pharmaceutical
WST
+$4.61M
2
STE icon
Steris
STE
+$4.13M
3
IDXX icon
Idexx Laboratories
IDXX
+$2.03M
4
ROP icon
Roper Technologies
ROP
+$1.78M
5
SPGI icon
S&P Global
SPGI
+$1.77M

Sector Composition

Rank Sector Weight
1 Technology 32.57%
2 Industrials 22.38%
3 Healthcare 13.49%
4 Financials 12.79%
5 Consumer Discretionary 5.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
51
Berkshire Hathaway Class B
BRK.B
$1.12T
$423K 0.12%
1,185
-55
-4% -$19.3K
XOM icon
52
ExxonMobil
XOM
$675B
$420K 0.12%
4,205
-158
-4% -$16.6K
PAYX icon
53
Paychex
PAYX
$41.8B
$393K 0.11%
3,300
-400
-11% -$47.4K
MAR icon
54
Marriott International
MAR
$87.6B
$387K 0.11%
1,718
IYW icon
55
iShares US Technology ETF
IYW
$25.2B
$368K 0.1%
3,000
-120
-4% -$13.6K
CSX icon
56
CSX Corp
CSX
$89.1B
$257K 0.07%
7,400
JNJ icon
57
Johnson & Johnson
JNJ
$646B
$251K 0.07%
1,600
+17
+1% +$2.61K
DLR icon
58
Digital Realty Trust
DLR
$67.8B
$229K 0.06%
1,700
-100
-6% -$12.9K
KO icon
59
Coca-Cola
KO
$380B
$221K 0.06%
3,750
DVY icon
60
iShares Select Dividend ETF
DVY
$23.2B
$207K 0.06%
+1,766
New +$194K
ENPH icon
61
Enphase Energy
ENPH
$4.68B
-12,698
Closed -$1.53M

Similar funds

Carderock Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Carderock Capital Management held 62 positions worth $362M, up 22% from $298M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Carderock Capital Management deployed $28.6M of net new capital in Q4 2023, opening 5 new positions and adding to 37 existing holdings. Its largest new stake was West Pharmaceutical: 13,033 shares worth $4.59M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Pool Corp, an estimated $1.52M trimmed.

  • Carderock Capital Management's largest Q4 2023 buy was West Pharmaceutical: 13,033 shares worth $4.59M.
  • Carderock Capital Management added most to Idexx Laboratories in Q4 2023, an estimated $2.03M increase.
  • Carderock Capital Management's biggest Q4 2023 reduction was Pool Corp, cutting an estimated $1.52M.
  • Carderock Capital Management fully exited Enphase Energy in Q4 2023, selling an estimated $1.53M.
  • Carderock Capital Management's ten largest holdings make up 31% of its $362M portfolio in Q4 2023.
  • Carderock Capital Management opened 5 new positions and closed 1 in Q4 2023.
  • Carderock Capital Management's portfolio value rose 22% quarter-over-quarter to $362M.

Based on Carderock Capital Management's 13F filing for Q4 2023, filed 23 Jan 2024.